Challenges and opportunities in oncology drug development and clinical research in China.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 38552607.
- Also identified by DOI 10.1016/j.cell.2024.02.040.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
As one of the world's most populous countries, China bears a heavy burden and a broad spectrum of cancers, including unique types, providing a unique environment for drug research and development. In recent years, China has leapt forward in oncology drug development and clinical trials, presenting new opportunities and challenges.
Medical subject headings
- Drug Development
- Medical Oncology
- Neoplasms
- Antineoplastic Agents